Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Regorafenib”

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05370807
What this trial is testing

A Clinical Trial of Regorafenib in Patients With Pretreated Advanced Melanoma

Who this might be right for
Melanoma Stage IIIMelanoma Stage IV
Universitair Ziekenhuis Brussel 48
Testing effectiveness (Phase 2)Study completedNCT02699073
What this trial is testing

Evaluation of Treatment Response With CHOI and RECIST Criteria and CT Texture Analysis in Patients With Metastatic Colorectal Cancer Treated With Regorafenib

Who this might be right for
Metastatic Colorectal Cancer
GERCOR - Multidisciplinary Oncology Cooperative Group 55
Not applicableStudy completedNCT06029010
What this trial is testing

An Observational Study to Learn More About the Long-Term Responses to Treatment With Regorafenib in Patients With Metastatic Colorectal Cancer in the United States

Who this might be right for
Metastatic Colorectal Cancer
Bayer 2,326
Testing effectiveness (Phase 2)Ended earlyNCT02402036
What this trial is testing

A Biomarker Study in Patients Getting Regorafenib for Metastatic Colorectal Cancer

Who this might be right for
Colon Cancer
Georgetown University 10
Not applicableStudy completedNCT01996969
What this trial is testing

Identification of Predictive Biomarker of Regorafenib in Refractory Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Seoul National University Hospital 117
Testing effectiveness (Phase 2)Looking for participantsNCT07040228
What this trial is testing

A Phase Ib/II Clinical Study of Regorafenib Combined With Toripalimab and Albumin-bound Paclitaxel for the Third-line Treatment of Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Metastatic
Junjie Hang 23
Testing effectiveness (Phase 2)UnknownNCT05753163
What this trial is testing

Hepatic Arterial Infusion Chemotherapy Combined With Sintilimab and Regorafenib as Adjuvant Therapy for Colorectal Liver Metastasis Patients With a High Risk of Recurrent: a Single-arm, Phase II Study

Who this might be right for
Colorectal Liver Metastasis
Fudan University 44
Testing effectiveness (Phase 2)Looking for participantsNCT05366816
What this trial is testing

CtDNA-Guided Sunitinib And Regorafenib Therapy for GIST

Who this might be right for
Gastrointestinal Stromal Tumors
University of Miami 48
Early research (Phase 1)Study completedNCT02116894
What this trial is testing

Safety Study of Regorafenib With PF-03446962 to Treat Colorectal Cancer

Who this might be right for
Colorectal Cancer
Duke University 11
Testing effectiveness (Phase 2)Study completedNCT04787341
What this trial is testing

PAnitumumab REchallenge Followed by REgorafenib Versus the Reverse Sequence

Who this might be right for
Colorectal Cancer
Gruppo Oncologico del Nord-Ovest 213
Early research (Phase 1)Study completedNCT06095375
What this trial is testing

Regorafenib With Temozolomide With or Without RT in MGMT-Methylated, IDH Wild-type GBM Patients

Who this might be right for
Glioblastoma, IDH-wildtypeMGMT-Methylated Glioblastoma
Istituto Oncologico Veneto IRCCS 21
Testing effectiveness (Phase 2)Looking for participantsNCT06558773
What this trial is testing

GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.

Who this might be right for
Colorectal Cancer
Chinese PLA General Hospital 120
Not applicableStudy completedNCT04920422
What this trial is testing

RE-SEARCH Study: A Study to Learn How and in Which Amount Regorafenib is Given in Usual Practice to Patients in Spain: a Study Looking Back at Cases That Have Already Happened When the Study Begins.

Who this might be right for
Metastatic Colorectal Cancer
Bayer 242
Testing effectiveness (Phase 2)Study completedNCT02638766
What this trial is testing

Single Agent Regorafenib in First-line for Metastatic/Unresectable KIT/PDGFR Wild Type GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Grupo Espanol de Investigacion en Sarcomas 15
Not applicableUnknownNCT05573282
What this trial is testing

Observation Study of Sequential Regorafenib Plus ICIs After HAIC for Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Sun Yat-sen University 50
Not applicableStudy completedNCT03386825
What this trial is testing

Metastatic Colorectal Cancer Patients With Long-term Response to Regorafenib

Who this might be right for
Colorectal Neoplasms
Bayer 76
Testing effectiveness (Phase 2)Study completedNCT03609424
What this trial is testing

PDR001 Plus Imatinib for Metastatic or Unresectable GIST

Who this might be right for
Gastrointestinal Stromal Tumors
Asan Medical Center 39
Testing effectiveness (Phase 2)WithdrawnNCT05582031
What this trial is testing

Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers

Who this might be right for
Anal Squamous Cell CarcinomaColorectal NeoplasmsSoft Tissue Sarcoma+5 more
Translational Research in Oncology
Early research (Phase 1)Study completedNCT02106845
What this trial is testing

Effect of Regorafenib on Digoxin and Rosuvastatin in Patients With Advanced Solid Malignant Tumors.

Who this might be right for
Neoplasms
Bayer 42
Testing effectiveness (Phase 2)UnknownNCT05970705
What this trial is testing

Regorafenib Combined With TAS-102 Versus Regorafenib Monotherapy in Third or Later Line Therapy of mCRC

Who this might be right for
Metastatic Colorectal Cancer
Fudan University 101
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation